View Author
c 1-inh patient melanoma attack study 1-inh 1-inhibitor c 1-inhibitor angioedema chromosome treatment iris melanomas prophylactic level inhibitor range c 1 inhibitor c 4 levels product pharmacokinetic netherland chromosome 3 prophylactic study uveal iris melanoma cetor uveal melanoma number spindle prophylactic treatment chromosomal parameter epithelioid result department ciliary body medication c 4 level chromosome 9 p safety activity prophylaxi angioedema attacks process ciliary on-demand study efficacy hae patients manufacturing process tumour table on-demand allergy group diagnosis analysis blood concentration c 1-inhibitor levels immunol c 1inh chromosome 10 q c 1-inhibitor antigen aae patient therapy allergy asthma immunol tumours administration ophthalmol cancer period mutation event plasma probe virus metastatic disease choroidal allergy clin aberration
2 Most Recent Publications
|
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
(Article)
Hofstra, J.J.H. Budde, I.K. Strengers, P.F.W. Twuyver, E. van Choi, G. Levi, M. Leebeek, F.W.G. Monchy, J.G. de Ypma, P.F. Keizer, R.J.W. de Huitema, A.D.R. |
2012-03-01
|
|
Chromosomal aberrations in iris melanomas
(Article)
Mensink, H.W. Vaarwater, J. Keizer, R.J.W. de Wolff-Rouendaal, D. de Mooy, C.M. Klein, J.E.M.M. de Paridaens, D. |
2011-03-01
|
